Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 288, Suchdauer: 0.77s

12 3 4 5 6 7 8 9 10 11 weiter »

1
784 Immune profiling of patients with advanced melanoma intratumorally treated with CV8102 as a single-agent or in combination with anti-PD-1 antibodies – results of a phase I trial expansion

von Gonzalez, Marina ; Wengenmayer, Peter ; Samoylenko, Igor ; et al.

Regular and Young Investigator Award Abstracts ; page A816-A816
- View full text via BASE
Merkliste

2
473 Immune profiling of patients with advanced solid tumors treated with intratumorally administered CV8102 as a single-agent or in combination with anti-PD-1 antibodies in phase I clinical trial

von Codó, Paula ; Eigentler, Thomas ; Heinzerling, Lucie ; et al.

Regular and Young Investigator Award Abstracts ; page A502-A502
- View full text via BASE
Merkliste

3
Identification of Classes of Functioning Trajectories and Their Predictors in Individuals With Spinal Cord Injury Attending Initial Rehabilitation in Switzerland

von Jsabel Hodel, MSc ; Cristina Ehrmann, PhD ; Anke Scheel-Sailer, MD ; et al.

Archives of Rehabilitation Research and Clinical Translation, Vol 3, Iss 2, Pp 100121- (2021)

Schlagworte: Latent class analysis; Logistic models; Longitudinal studies; Observational study; Rehabilitation; Spinal cord injuries; Medicine (General); R5-920
- View full text via DOI
Merkliste

4
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

von Alexandros Papachristofilou ; Madeleine M. Hipp ; Ute Klinkhardt ; et al.

Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)

Schlagworte: Clinical trial; Hypofractionated radiotherapy; Immunomonitoring; mRNA active cancer immunotherapy; Non-small cell lung cancer; BI1361849; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

5
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

von Sebastian, Martin ; Schröder, Andreas ; Scheel, Birgit ; et al.

Cancer Immunology, Immunotherapy. 68(5):799-812
- Zum Volltext in PubMed Central
Merkliste

6
Outline of an Empirical Study on the Effects of Emotions on Strategic Behavior in Virtual Emergencies

von Becker-Asano, Christian ; Sun, Dali ; Kleim, Birgit ; et al.

Affective Computing and Intelligent Interaction : Fourth International Conference, ACII 2011, Memphis, TN, USA, October 9–12, 2011, Proceedings, Part II. 6975:508-517
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

7
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

von Papachristofilou, Alexandros ; Hipp, Madeleine M. ; Klinkhardt, Ute ; et al.

Schlagworte: ddc-610; 610 Medical sciences Medicine
- View full text via BASE
Merkliste

8
Administration of assessment instruments during the first rehabilitation of patients with spinal cord injury: a retrospective chart analysis

von Lampart, Patricia ; Gemperli, Armin ; Baumberger, Michael ; et al.

Spinal Cord. 56(4):322-331
- Zum Volltext (via ReDI)
Merkliste

9
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

von Kübler, Hubert ; Scheel, Birgit ; Gnad-Vogt, Ulrike ; et al.
- View full text via BASE
Merkliste

10
RNAdjuvant®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile

von Lutz, Johannes ; Heidenreich, Regina ; Mehr, Keyvan Tadjalli ; et al.

The Journal of Immunology ; volume 198, issue Supplement_1, page 79.7-79.7 ; ISSN 0022-1767 1550-6606
- View full text via BASE
Merkliste

11
P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

von Papachristofilou, Alexandros ; Sebastian, Martin ; Weiss, Christian ; et al.

Journal of Thoracic Oncology ; volume 12, issue 1, page S1333-S1334 ; ISSN 1556-0864
- View full text via BASE
Merkliste

12
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

von Lundqvist, Andreas ; van Hoef, Vincent ; Zhang, Xiaonan ; et al.
- View full text via BASE
Merkliste

13
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy

von Hong, Henoch S. ; Koch, Sven D. ; Scheel, Birgit ; et al.

OncoImmunology ; volume 5, issue 12, page e1249560 ; ISSN 2162-402X
- View full text via BASE
Merkliste

14
RNAdjuvant®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile

von Heidenreich, Regina ; Mehr, Keyvan ; Noth, Janine ; et al.

Journal for ImmunoTherapy of Cancer ; volume 3, issue Suppl 2, page P163 ; ISSN 2051-1426
- View full text via BASE
Merkliste

15
A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile

von Heidenreich, Regina ; Jasny, Edith ; Kowalczyk, Aleksandra ; et al.

International Journal of Cancer ; volume 137, issue 2, page 372-384 ; ISSN 0020-7136 1097-0215
- View full text via BASE
Merkliste

16
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

von Sebastian, Martin ; Papachristofilou, Alexandros ; Weiss, Christian ; et al.

BMC Cancer ; volume 14, issue 1 ; ISSN 1471-2407
- View full text via BASE
Merkliste

17
A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part

von Koch, Sven D ; Hong, Henoch ; Feyerabend, Susan ; et al.

Journal for ImmunoTherapy of Cancer ; volume 2, issue Suppl 3, page P85 ; ISSN 2051-1426
- View full text via BASE
Merkliste

18
Self-adjuvanted RNActive® vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans

von Kowalczyk, Aleksandra ; Döner, Fatma ; Jasny, Edith ; et al.

Journal for ImmunoTherapy of Cancer ; volume 2, issue S3 ; ISSN 2051-1426
- View full text via BASE
Merkliste

19
A phase I/IIa study of the mRNA based cancer vaccine CV9103 prepared with the RNActive technology results in distinctly longer survival than predicted by the Halabi Nomogram which correlates with the induction of antigen-specific immune responses

von Kallen, Karl-Josef ; Gnad-Vogt, Ulrike ; Scheel, Birgit ; et al.

Journal for ImmunoTherapy of Cancer ; volume 1, issue S1 ; ISSN 2051-1426
- View full text via BASE
Merkliste

20
A novel, disruptive vaccination technology ; Self-adjuvanted RNActive ® vaccines

von Kallen, Karl-Josef ; Heidenreich, Regina ; Schnee, Margit ; et al.

Human Vaccines & Immunotherapeutics ; volume 9, issue 10, page 2263-2276 ; ISSN 2164-5515 2164-554X
- View full text via BASE
Merkliste

21
Characterization of the ribonuclease activity on the skin surface

von Probst, Jochen ; Brechtel, Sonja ; Scheel, Birgit ; et al.

Genetic Vaccines and Therapy ; volume 4, issue 1 ; ISSN 1479-0556
- View full text via BASE
Merkliste

22
Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA

von Scheel, Birgit ; Teufel, Regina ; Probst, Jochen ; et al.

European Journal of Immunology ; volume 35, issue 5, page 1557-1566 ; ISSN 0014-2980 1521-4141
- View full text via BASE
Merkliste

23
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas

von Carralot, Jean-Philippe ; Weide, Benjamin ; Schoor, Oliver ; et al.

Genetic Vaccines and Therapy ; volume 3, issue 1 ; ISSN 1479-0556
- View full text via BASE
Merkliste

24
Dieses Ergebnis aus wiso kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- View record at wiso
Merkliste

25
Dieses Ergebnis aus wiso kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- View record at wiso
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag